Rapid City Medical Center Llp | |
101 E Minnesota St Suite 210 Rapid City SD 57701-7756 | |
(605) 342-3280 | |
Not Available |
Full Name | Rapid City Medical Center Llp |
---|---|
Speciality | Clinic/Center |
Location | 101 E Minnesota St, Rapid City, South Dakota |
Authorized Official Name and Position | Darrel Riddle (CEO) |
Authorized Official Contact | 6053423280 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Rapid City Medical Center Llp Po Box 6020 Rapid City SD 57709-6020 Ph: () - | Rapid City Medical Center Llp 101 E Minnesota St Suite 210 Rapid City SD 57701-7756 Ph: (605) 342-3280 |
NPI Number | 1043577810 |
---|---|
Provider Enumeration Date | 04/18/2012 |
Last Update Date | 04/18/2012 |
Medicare PECOS PAC ID | 5890691075 |
---|---|
Medicare Enrollment ID | O20190607002061 |
News Archive
Greenwich Hospital surgical, labor and delivery, and oncology patients are among those who have received a healing boost through a form of energy therapy known as Healing Touch.The hospital, known for its reputation of service excellence, is among a growing number of medical facilities utilizing Healing Touch, which is a gentle, noninvasive therapy shown to facilitate the relaxation response to enhance the healing process. Research shows that, in addition to inducing a deep sense of calm and relaxation, Healing Touch helps to reduce pain, decrease anxiety, promote sleep and improve an overall sense of well-being.
An international group of researchers has shown that a regulatory protein involved in controlling how cancer spreads through the body also influences the fate of stem cells in the intestine of mice. The results, which are published in The EMBO Journal, show that the Snai1 protein plays an important role in deciding the fate of intestinal stem cells and the different functions that these cells can adopt.
People in Manitoba and Saskatchewan living with Chronic Lymphocytic Leukemia (CLL) will now be able to access a new treatment option through the prescription drug insurance plans in both provinces. Earlier this week, GAZYVA (obinutuzumab) in combination with chlorambucil chemotherapy was added to benefits formularies of the Provincial Oncology Drug Programs at CancerCare Manitoba and the Saskatchewan Cancer Agency.
A recent study led by Boston University School of Medicine (BUSM) demonstrates that the A2b-type adenosine receptor, A2bAR, plays a significant role in the regulation of high fat, high cholesterol diet-induced symptoms of type 2 diabetes.
› Verified 5 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1043577810 | NPI | - | NPPES |
CR0392 | Other | RAILROAD MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
261QM1300X | Clinic/center - Multi-specialty | (* (Not Available)) | Primary |
News Archive
Greenwich Hospital surgical, labor and delivery, and oncology patients are among those who have received a healing boost through a form of energy therapy known as Healing Touch.The hospital, known for its reputation of service excellence, is among a growing number of medical facilities utilizing Healing Touch, which is a gentle, noninvasive therapy shown to facilitate the relaxation response to enhance the healing process. Research shows that, in addition to inducing a deep sense of calm and relaxation, Healing Touch helps to reduce pain, decrease anxiety, promote sleep and improve an overall sense of well-being.
An international group of researchers has shown that a regulatory protein involved in controlling how cancer spreads through the body also influences the fate of stem cells in the intestine of mice. The results, which are published in The EMBO Journal, show that the Snai1 protein plays an important role in deciding the fate of intestinal stem cells and the different functions that these cells can adopt.
People in Manitoba and Saskatchewan living with Chronic Lymphocytic Leukemia (CLL) will now be able to access a new treatment option through the prescription drug insurance plans in both provinces. Earlier this week, GAZYVA (obinutuzumab) in combination with chlorambucil chemotherapy was added to benefits formularies of the Provincial Oncology Drug Programs at CancerCare Manitoba and the Saskatchewan Cancer Agency.
A recent study led by Boston University School of Medicine (BUSM) demonstrates that the A2b-type adenosine receptor, A2bAR, plays a significant role in the regulation of high fat, high cholesterol diet-induced symptoms of type 2 diabetes.
› Verified 5 days ago
James M. Keegan Md Professional Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4940 5th St, Suite 1b, Rapid City, SD 57701 Phone: 605-342-8329 | |
Rapid City Medical Center Llp Westside Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3810 Jackson Blvd, Rapid City, SD 57702 Phone: 605-343-4050 | |
Kirby Health Care, P. C. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1501 Centre St Ste 102, Rapid City, SD 57703 Phone: 605-484-9775 Fax: 605-343-3007 | |
Family Medicine Residency Clinic Part B Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 502 E Monroe St, Rapid City, SD 57701 Phone: 605-719-4060 Fax: 605-755-7884 | |
Swanson Chiropractic, P.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 420 E Saint Patrick St, 101, Rapid City, SD 57701 Phone: 605-721-6510 Fax: 605-721-6515 | |
Black Hills Hospitalist Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 101 E Minnesota St, Suite 261, Rapid City, SD 57701 Phone: 605-718-7450 Fax: 605-718-7465 |